Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.

Macdonald JA, Bronner IF, Drynan L, Fan J, Curry A, Fraser G, Lavenir I, Goedert M.

Acta Neuropathol Commun. 2019 Mar 18;7(1):44. doi: 10.1186/s40478-019-0695-5.

2.
3.

A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRAS.

Bao L, Al-Assar O, Drynan LF, Arends MJ, Tyers P, Barker RA, Rabbitts TH.

Sci Rep. 2017 Mar 21;7:44899. doi: 10.1038/srep44899.

4.

Analysis of core circadian feedback loop in suprachiasmatic nucleus of mCry1-luc transgenic reporter mouse.

Maywood ES, Drynan L, Chesham JE, Edwards MD, Dardente H, Fustin JM, Hazlerigg DG, O'Neill JS, Codner GF, Smyllie NJ, Brancaccio M, Hastings MH.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9547-52. doi: 10.1073/pnas.1220894110. Epub 2013 May 20.

5.

Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Camelo A, Barlow JL, Drynan LF, Neill DR, Ballantyne SJ, Wong SH, Pannell R, Gao W, Wrigley K, Sprenkle J, McKenzie AN.

J Gastroenterol. 2012 Nov;47(11):1198-211. doi: 10.1007/s00535-012-0591-2. Epub 2012 Apr 27.

6.

Transcription factor RORα is critical for nuocyte development.

Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V, Koch U, Radtke F, Hardman CS, Hwang YY, Fallon PG, McKenzie AN.

Nat Immunol. 2012 Jan 22;13(3):229-36. doi: 10.1038/ni.2208.

7.

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity.

Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, McKenzie AN.

J Allergy Clin Immunol. 2012 Jan;129(1):191-8.e1-4. doi: 10.1016/j.jaci.2011.09.041. Epub 2011 Nov 12.

PMID:
22079492
8.

Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.

Finch AJ, Hilcenko C, Basse N, Drynan LF, Goyenechea B, Menne TF, González Fernández A, Simpson P, D'Santos CS, Arends MJ, Donadieu J, Bellanné-Chantelot C, Costanzo M, Boone C, McKenzie AN, Freund SM, Warren AJ.

Genes Dev. 2011 May 1;25(9):917-29. doi: 10.1101/gad.623011.

9.

New insights into 5q- syndrome as a ribosomopathy.

Barlow JL, Drynan LF, Trim NL, Erber WN, Warren AJ, McKenzie AN.

Cell Cycle. 2010 Nov 1;9(21):4286-93. Epub 2010 Nov 22. Review.

PMID:
20980806
10.

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.

Pellagatti A, Marafioti T, Paterson JC, Barlow JL, Drynan LF, Giagounidis A, Pileri SA, Cazzola M, McKenzie AN, Wainscoat JS, Boultwood J.

Blood. 2010 Apr 1;115(13):2721-3. doi: 10.1182/blood-2009-12-259705. No abstract available.

PMID:
20360478
11.

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.

Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL, Jolin HE, Pannell R, Middleton AJ, Wong SH, Warren AJ, Wainscoat JS, Boultwood J, McKenzie AN.

Nat Med. 2010 Jan;16(1):59-66. doi: 10.1038/nm.2063. Epub 2009 Nov 22.

12.

Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.

Appert A, Nam CH, Lobato N, Priego E, Miguel RN, Blundell T, Drynan L, Sewell H, Tanaka T, Rabbitts T.

Cancer Res. 2009 Jun 1;69(11):4784-90. doi: 10.1158/0008-5472.CAN-08-4774.

13.

Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias.

Lobato MN, Metzler M, Drynan L, Forster A, Pannell R, Rabbitts TH.

J Natl Cancer Inst Monogr. 2008;(39):58-63. doi: 10.1093/jncimonographs/lgn022.

PMID:
18648005
14.

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.

Nam CH, Lobato MN, Appert A, Drynan LF, Tanaka T, Rabbitts TH.

Oncogene. 2008 Aug 21;27(36):4962-8. doi: 10.1038/onc.2008.130. Epub 2008 Apr 28.

PMID:
18438427
15.

Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.

Cano F, Drynan LF, Pannell R, Rabbitts TH.

Oncogene. 2008 Mar 20;27(13):1945-50. Epub 2007 Oct 1.

PMID:
17906700
16.

Chromosomal translocation engineering to recapitulate primary events of human cancer.

Forster A, Pannell R, Drynan L, Cano F, Chan N, Codrington R, Daser A, Lobato N, Metzler M, Nam CH, Rodriguez S, Tanaka T, Rabbitts T.

Cold Spring Harb Symp Quant Biol. 2005;70:275-82.

PMID:
16869763
17.

Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.

Drynan LF, Pannell R, Forster A, Chan NM, Cano F, Daser A, Rabbitts TH.

EMBO J. 2005 Sep 7;24(17):3136-46. Epub 2005 Aug 11.

18.

The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells.

Codrington R, Pannell R, Forster A, Drynan LF, Daser A, Lobato N, Metzler M, Rabbitts TH.

PLoS Biol. 2005 Aug;3(8):e242. Epub 2005 Jun 28.

19.

The invertor knock-in conditional chromosomal translocation mimic.

Forster A, Pannell R, Drynan LF, Codrington R, Daser A, Metzler M, Lobato MN, Rabbitts TH.

Nat Methods. 2005 Jan;2(1):27-30.

PMID:
15782166
20.
21.

Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer.

Forster A, Pannell R, Drynan LF, McCormack M, Collins EC, Daser A, Rabbitts TH.

Cancer Cell. 2003 May;3(5):449-58.

22.

T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity.

Drynan LF, Hamilton TL, Rabbitts TH.

Oncogene. 2001 Jul 19;20(32):4412-5.

PMID:
11466623
23.

Mouse models of human chromosomal translocations and approaches to cancer therapy.

Rabbitts TH, Appert A, Chung G, Collins EC, Drynan L, Forster A, Lobato MN, McCormack MP, Pannell R, Spandidos A, Stocks MR, Tanaka T, Tse E.

Blood Cells Mol Dis. 2001 Jan-Feb;27(1):249-59. Review.

PMID:
11358385
26.

Top-down regulation analyses of palmitoyl-CoA oxidation and ketogenesis in isolated rat liver mitochondria.

Makins RA, Drynan LF, Zammit VA, Quant PA.

Biochem Soc Trans. 1995 May;23(2):288S. No abstract available.

PMID:
7672314

Supplemental Content

Loading ...
Support Center